Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DAPAGLIFLOZIN for Immunisation: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 13 adverse event reports in the FDA FAERS database where DAPAGLIFLOZIN was used for Immunisation.

Most Reported Side Effects for DAPAGLIFLOZIN

Side Effect Reports % Deaths Hosp.
Death 2,775 13.0% 2,774 52
Diabetic ketoacidosis 1,773 8.3% 61 1,154
Acute kidney injury 982 4.6% 67 768
Off label use 891 4.2% 28 310
Nausea 884 4.1% 20 363
Dehydration 860 4.0% 67 451
Vomiting 838 3.9% 27 419
Dizziness 817 3.8% 30 293
Ketoacidosis 803 3.8% 30 471
Fatigue 785 3.7% 8 227
Diarrhoea 769 3.6% 32 317
Dyspnoea 760 3.6% 21 328
Malaise 737 3.5% 30 308
Weight decreased 727 3.4% 23 231
Blood glucose increased 699 3.3% 12 247

Other Indications for DAPAGLIFLOZIN

Type 2 diabetes mellitus (5,444) Diabetes mellitus (3,347) Product used for unknown indication (1,534) Cardiac failure (1,332) Chronic kidney disease (585) Ill-defined disorder (556) Cardiac failure chronic (498) Type 1 diabetes mellitus (308) Blood glucose increased (145) Blood glucose abnormal (127)

Other Drugs Used for Immunisation

INFLUENZA VIRUS VACCINE (560) PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE (281) COVID-19 VACCINE NOS (269) TOZINAMERAN (207) MEASLES VIRUS STRAIN ENDERS^ ATTENUATED EDMONSTON LIVE ANTIGEN\MUMPS VIRUS STRAIN B LEVEL JERYL LYNN LIVE ANTIGEN\RUBELLA VIRUS STRAIN WISTAR RA 27/3 LIVE ANTIGEN (152) TUBERCULIN PURIFIED PROTEIN DERIVATIVE (148) PNEUMOCOCCAL VACCINE POLYVALENT (140) VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN (123) AD26.COV2.S (113) STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE A (111)

Related Pages

DAPAGLIFLOZIN Full Profile All Immunisation Drugs DAPAGLIFLOZIN Demographics DAPAGLIFLOZIN Timeline